Microvascular and macrovascular complications in children and adolescents with type 1 diabetes mellitus;Typ-1-diabetes mellitus: Spätkomplikationen im kindes-Und jugendalter

Wiener Medizinische Wochenschrift

Volumn 160, Issue 15-16, 2010, Pages 414-418

  Fröhlich Reiterer, Elke E ^a   Borkenstein, Martin H ^a  

^a Universitatsklinik fur Kinder und Jugendheilkunde Graz   (Austria)

Author keywords

Adolescents; Children; Complications; Type 1 diabetes mellitus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADOLESCENT; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CHILD; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DYSLIPOPROTEINEMIA; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MICROALBUMINURIA; PUBERTY; REVIEW; RISK FACTOR; RISK REDUCTION; SCREENING; SMOKING;

ADOLESCENT; AGE FACTORS; BLOOD PRESSURE; BODY MASS INDEX; CHILD; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MASS SCREENING; MOTOR ACTIVITY; RISK FACTORS; SMOKING;

EID: 78149346520     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10354-010-0816-z     Document Type: Review

References (20)

1. DCCT (Diabetes Control and Complication Trial) Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. NEJM, 329:977-986, 1993.
2. Hürter P, Danne T. Diabetes bei Kindern und Jugendlichen. 6. Auflage. Springer-Verlag, Berlin, 2005.
3. Krolewski AS, Warram JH, Christlieb AR, et al. The changing natural history of nephropathy in type 1 diabetes. Am J Med, 78:785-794, 1985.
4. Donaghue KC, Chiarelli F, Trotta D, et al. Microvascular and macrovascular complications. ISPAD Clinical practice consensus guidelines 2006-2007. Pediatr Diabetes, 10 (Suppl 12):195-203, 2009.
5. Maguire A, Chan A, Cusumano J, et al. The case for biennial retinopathy screening in children and adolescents. Diabetes Care, 28:509-513, 2005.
6. Hutchinson A, McIntosch A, Peters J, et al. Effectiveness of screening and monitoring tests for diabetic retinopathy - a systematic review. Diabet Med, 17:495-506, 2000.
7. Bailey CC, Sparrow JM, Grey RH, et al. The national diabetic retinopathy laser treatment audit III. Clinical outcomes. Eye, 13:151-159, 1999.
8. Mogensen CE, Keane WF, Bennett PH. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet, 346:1080-1084, 1995.
9. Stone ML, Craig ME, Chan AK. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes: a longitudinal study. Diabetes Care, 29:2071-2077, 2006.
10. De Man SA, Andre JL, Bachmann H, et al. Blood pressure in childhood: pooled findings of six European studies. J Hypertens, 9:109-114, 1991.
11. Soffer B, Zhang Z, Miller K. Adouble-blind, placebo-controlled, doseresponse study of the effectiveness and safety of lisonopril for children with hypertension. Am J Hypertens, 16:795-800, 2003.
12. Chiarelli F, Dahl-Jorgensen KD, Kiess W (eds) Diabetes in childhood and adolescence, Vol 10. Pediatr Adolesc Med, Basel, Karger, 2005.
13. Young MJ, Boulton AJ, MacLeod AF, et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 36:150-154, 1993.
14. Laing SP, Swerdlow AJ, Slater SD, et al. Mortality from heart disease in a cohort of 23, 000 patients with inulin-treated diabetes. Diabetologia, 46:760-765, 2003.
15. Stammler J, Vaccaro O, Neaton JD. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in Multiple Risk Factor Intervention Trial. Diabetes Care, 16:434-444, 1993.
16. Makimattila S, Ylitalo K, Schlenzka A, et al. Family histories of Type II diabetes and hypertension predict intima-media thickness in patients with Type I diabetes. Diabetologia, 45:711-718, 2002.
17. Maser RE, Mitchell BD, Vinik AI, et al. The association between cardiovascular autonomic neuropathy and mortality in individuals with diabetes: a meta-analysis. Diabetes Care, 26:1895-1901, 2003.
18. Collins R, Armitage J, Parish S, et al. Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet, 361:2005-2016, 2003.
19. De Jongh S, Ose L, Szamosi T, et al. Simvastatin in Children Study Group: Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation, 2231-2237, 2002.
20. Nordwall M, Arnqvist HJ, Bojesting M, et al. Good glycemic control remains crucial in prevention of late complications - the Linköping Diabetes Complications Study. Pediatr Diabetes, 10:168-176, 2009.